Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Llorca

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 16, 2018
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohortG Fond, E Bulzacka, M Boucekine, et al.
Schizophrenia Research|November 22, 2015
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ datasetF Berna, D Misdrahi, L Boyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 25, 2022
Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort studyG Fond, J Dubreucq, P L Sunhary de Verville, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 27, 2017
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohortG Fond, F Berna, M Andrianarisoa, et al.
Schizophrenia Research|October 5, 2017
Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohortG Fond, L Boyer, M Leboyer, et al.
Schizophrenia Research|August 11, 2015
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohortO Godin, M Leboyer, A Gaman, et al.
Schizophrenia Research|January 23, 2017
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohortM Andrianarisoa, L Boyer, O Godin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 17, 2020
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Journal of Affective Disorders|June 24, 2025
Substance use disorders in outpatients with bipolar disorder and pain complaintsJ Chabert, R Icick, J Cabé, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 14, 2021
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohortP L Sunhary de Verville, D Etchecopar-Etchart, R Richieri, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 16, 2018
Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohortG Fond, E Bulzacka, M Boucekine, et al.
Schizophrenia Research|November 22, 2015
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ datasetF Berna, D Misdrahi, L Boyer, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 25, 2022
Early-life factors associated with increased risk of disability pension in the national real-world schizophrenia FACE-SZ cohort studyG Fond, J Dubreucq, P L Sunhary de Verville, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 27, 2017
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohortG Fond, F Berna, M Andrianarisoa, et al.
Schizophrenia Research|October 5, 2017
Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohortG Fond, L Boyer, M Leboyer, et al.
Schizophrenia Research|August 11, 2015
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohortO Godin, M Leboyer, A Gaman, et al.
Schizophrenia Research|January 23, 2017
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohortM Andrianarisoa, L Boyer, O Godin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 17, 2020
Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohortG Fond, O Godin, F Schürhoff, et al.
Journal of Affective Disorders|June 24, 2025
Substance use disorders in outpatients with bipolar disorder and pain complaintsJ Chabert, R Icick, J Cabé, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 14, 2021
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohortP L Sunhary de Verville, D Etchecopar-Etchart, R Richieri, et al.
Pageof 17